Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity
about
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyMirtazapine inhibits tumor growth via immune response and serotonergic systemThe immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceChronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulationInvolvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing miceOral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patientsIndoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseasesImmunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapiesThe control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilingsInterferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression.The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles.Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity.The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages.Chemoimmunotherapy as long-term maintenance therapy for cancer.Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity.Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.Indoleamine 2,3-dioxygenase expression in early keratocyte neoplasia of the lower lip correlates to the degree of cell atypia.
P2860
Q27002646-1E1267EA-08F1-461B-A2DB-91936D0E23F5Q28481311-BCF05233-4CC1-4ACB-9D2A-5F04CC66041BQ34219774-FCD6C09D-E445-4FD4-A58C-6619A810CE89Q34512092-13E15864-F179-40AA-96B1-B39A03BE902EQ35269390-10C0687D-7B1F-4932-94B5-3CAAB78B0CD1Q35370968-33721F03-BE4D-4DCE-97BC-B756FF0A83EAQ36338435-9FFCBE58-39C1-4D24-A552-FDB320B4AE46Q36755475-19DD4D28-DBBF-4C4B-8D07-59DA83034147Q36808542-A18E7E18-8C40-4E4F-B342-CC105D71CDD5Q36821053-7BCD223C-D917-4174-AD11-5E463EDC6BB6Q36973676-4CCF0845-A150-4409-98E5-C76046D8EB01Q36984717-B6A0D661-1497-4553-B37D-17015CE9B2E9Q37047061-0947911F-5EB8-425C-8823-2A195AC197FBQ37249406-CAB1BFA3-35D6-471B-B3E2-A14597B01E50Q37350929-77FAE04A-2E4F-47E2-B10C-72C1A0822C11Q38021845-C4A62872-2F1C-42E1-8B4D-E37BC87CA481Q38025094-EE1CF237-A0E9-4B37-8BE8-3345B0095C6FQ38047057-2F1BFC5A-044B-48C9-B710-235AF0B46991Q38363548-8C96DF84-F687-42D4-8E01-8B6C89614D8BQ38985262-007C5C38-8486-4831-8F44-9E7DF52C6E30Q39075478-92D8194A-CFDC-4852-8716-BD2D9C9E495EQ39532160-A3DF58F1-D165-4961-8418-679F7B09A5F1Q39679210-B0BFB6C1-37EC-49FC-B8D1-2806C92EB5F2Q42087809-16FFC22F-FAC6-4AD7-A45A-46916875EE33Q45857246-2C7FD77D-1BD4-4B2C-A515-25F98F6C5339Q45865862-8D319138-CC81-45CE-8322-781B4CDEF240Q48194798-654420F5-9F46-4A66-BF64-EEB396342169Q52657150-F9BDCB91-01C5-4FFF-A984-FD2A50294081Q53275838-1C2A2B50-C140-41EF-8FC1-C41F0444BE9A
P2860
Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@en
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@nl
type
label
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@en
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@nl
prefLabel
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@en
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@nl
P2093
P2860
P1433
P1476
Central role of IFNgamma-indol ...... 12-mediated antitumor immunity
@en
P2093
Mehmet O Kilinc
Nejat K Egilmez
Rachael B Rowswell-Turner
P2860
P304
P356
10.1158/0008-5472.CAN-09-3170
P407
P577
2009-12-22T00:00:00Z